100 mg/ml
Trade Name
OMVOH
Solution for injection in pre-filled syringe
Request Type
New Registration
Drug Type
Biological
Approval Date
SFDA Approved Use
Mirikizumab is indicated for the treatment of moderately to severely active ulcerative colitis in adults.